TrueTicker

NIFTY 500 › Healthcare

Healthcare · NIFTY 500

NATCO Pharma Ltd.

NATCOPHARM on NSE · 19 Nov 2026

NIFTY 500

821.95 ▲ +0.16 % on the day

NATCO Pharma Ltd. (NATCOPHARM) closed at ₹821.95 on 19 Nov 2026, up 0.16 % on the day. It is unchanged over the past year; it stands 33.0 % below its 52-week high; it trades below its 200-day average. Its P/E is 12.9 on the last four quarters' profit. In Q1 FY27 (Apr-Jun 2026), profit fell 57.0 % and revenue fell 44.7 % from a year earlier, as the company reported. It is part of the NIFTY 500, in the Healthcare sector.

Overview Technical Risk & rank Quality Results Accounts Filings Guidance & governance

NATCOPHARM · last year19 Nov 2026

The line uses prices adjusted for splits, bonuses and similar events.

1 week+1.6 %
1 month+2.6 %
3 months-8.5 %
1 year-0.0 %
From 52-week high-33.0 %distance from its highest close of the last year
200-day averageBelowprice above or below its 200-day average
P/E12.9on the last four quarters' profit
Typical daily turnover38.3₹ cr, median day of the last 60
Delivery51 %of traded shares taken into demat (not squared off)

Results in short

Q1 FY27 (Apr-Jun 2026), as the company reported it.

Revenue735₹ cr in the quarter, -44.7 % YoY
Profit206₹ cr in the quarter, -57.0 % YoY
Profit margin28.1 %profit as a share of revenue
Return on equity12.4 %ROE: last four quarters' profit on shareholders' funds

All 34 quarters

NATCO Pharma Ltd. is part of the NIFTY 500. Figures are consolidated, from the company's results filed with NSE. Quality checks and outlook cover NIFTY 50 companies only, for now.

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in